Increased lipoxygenase and decreased cytochrome P450s metabolites correlated with the incidence of diabetic nephropathy: Potential role of eicosanoids from metabolomics in type 2 diabetic patients-Reference-Cited by-同舟云学术

Increased lipoxygenase and decreased cytochrome P450s metabolites correlated with the incidence of diabetic nephropathy: Potential role of eicosanoids from metabolomics in type 2 diabetic patients

Published:2021-02-19 Issue:5 Volume:48 Page:679-685
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:Clin Exp Pharmacol Physiol

Author:

Peng Liyuan¹,Sun Bei²,Liu Yajin²,Huang Jing³,Chen Guangzhi¹,Zhang Xu³,Chen Chen¹,Wang Daowen¹,Wang Gang⁴

Affiliation:

1. Division of Cardiology Department of Internal Medicine Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

2. NHC Key Laboratory of Hormones and Development Tianjin Key Laboratory of Metabolic Diseases Chu Hsien‐I Memorial Hospital & Tianjin Institute of Endocrinology Tianjin Medical University Tianjin China

3. Tianjin Key Laboratory of Metabolic Diseases Key Laboratory of Immune Microenvironment and Disease‐Ministry of Education Department of Physiology and Pathophysiology Collaborative Innovation Center of Tianjin for Medical Epigenetics Tianjin Medical University Tianjin China

4. Department of Critical Care Medicine The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1440-1681.13471

Reference26 articles.

1. Diabetic Nephropathy: Diagnosis, Prevention, and Treatment

2. Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management

3. Effects of polyunsaturated fatty acid consumption in diabetic nephropathy

4. Prevalence of diabetic nephropathy among Type 2 diabetic patients in some of the Arab countries;Aldukhayel A;Int J Health Sci,2017

5. Diabetic nephropathy in type 1 diabetes;Papadopoulou‐Marketou N;Minerva Med,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The circ_0003928/miR-31-5p/MAPK6 cascade affects high glucose-induced inflammatory response, fibrosis and oxidative stress in HK-2 cells;Transplant Immunology;2024-10

2. Advancements, Challenges, and clinical implications of integration of metabolomics technologies in diabetic nephropathy;Clinica Chimica Acta;2024-07

3. Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease;Antioxidants;2024-04-12

4. Metabolomics: A New Tool to Reveal the Nature of Diabetic Kidney Disease;Laboratory Medicine;2022-06-24

5. Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-01